TD-9855 Phase 2 in Neurogenic Orthostatic Hypotension (nOH)

Conditions

• Neurogenic Orthostatic Hypotension
• Multiple System Atrophy (MSA) With Orthostatic Hypotension
• Pure Autonomic Failure
• Parkinson Disease
• Hypotension, Orthostatic
• Orthostatic Hypotension
• Pure Autonomic Failure With Orthostatic Hypotension
• Parkinson Disease With Orthostatic Hypotension

Interventions

• DRUG: TD-9855
• DRUG: Placebo

Sponsor

Theravance Biopharma